According to Zhitong Finance App, Nongshim Technology (001231.SZ) announced that the company's wholly-owned subsidiary, Shaanxi Shanggezhilu Bioscience Co., Ltd. (hereinafter referred to as “Shangge Road”), increased the capital of its holding subsidiary Shaanxi Yijianyi Bioengineering Co., Ltd. (hereinafter referred to as “One Simple One to”) with its own or self-funded capital of 141.3 million yuan. Following the completion of this capital increase, the registered capital from RMB150 million to RMB300 million will be increased from RMB150 million to RMB300 million.

Zhitongcaijing · 1d ago
According to Zhitong Finance App, Nongshim Technology (001231.SZ) announced that the company's wholly-owned subsidiary, Shaanxi Shanggezhilu Bioscience Co., Ltd. (hereinafter referred to as “Shangge Road”), increased the capital of its holding subsidiary Shaanxi Yijianyi Bioengineering Co., Ltd. (hereinafter referred to as “One Simple One to”) with its own or self-funded capital of 141.3 million yuan. Following the completion of this capital increase, the registered capital from RMB150 million to RMB300 million will be increased from RMB150 million to RMB300 million.